Mar Vista Investment Partners LLC held its position in Medtronic PLC (NYSE:MDT) during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 36,193 shares of the medical technology company’s stock at the close of the second quarter. Mar Vista Investment Partners LLC’s holdings in Medtronic PLC were worth $3,212,000 as of its most recent SEC filing.

A number of other large investors have also bought and sold shares of MDT. Hudock Capital Group LLC lifted its holdings in shares of Medtronic PLC by 0.5% in the second quarter. Hudock Capital Group LLC now owns 2,195 shares of the medical technology company’s stock valued at $194,000 after purchasing an additional 11 shares in the last quarter. Bollard Group LLC lifted its holdings in shares of Medtronic PLC by 0.4% in the second quarter. Bollard Group LLC now owns 3,651 shares of the medical technology company’s stock valued at $324,000 after purchasing an additional 14 shares in the last quarter. Triangle Securities Wealth Management lifted its holdings in shares of Medtronic PLC by 0.3% in the second quarter. Triangle Securities Wealth Management now owns 4,396 shares of the medical technology company’s stock valued at $390,000 after purchasing an additional 15 shares in the last quarter. IFC Holdings Incorporated FL lifted its holdings in shares of Medtronic PLC by 0.3% in the second quarter. IFC Holdings Incorporated FL now owns 5,673 shares of the medical technology company’s stock valued at $501,000 after purchasing an additional 17 shares in the last quarter. Finally, North Star Investment Management Corp. lifted its holdings in shares of Medtronic PLC by 1.1% in the second quarter. North Star Investment Management Corp. now owns 1,995 shares of the medical technology company’s stock valued at $177,000 after purchasing an additional 22 shares in the last quarter. 81.37% of the stock is owned by hedge funds and other institutional investors.

TRADEMARK VIOLATION WARNING: “Medtronic PLC (MDT) Position Held by Mar Vista Investment Partners LLC” was first published by Daily Political and is owned by of Daily Political. If you are accessing this piece of content on another publication, it was stolen and reposted in violation of U.S. & international copyright law. The original version of this piece of content can be accessed at https://www.dailypolitical.com/2017/11/13/medtronic-plc-mdt-position-held-by-mar-vista-investment-partners-llc.html.

A number of analysts have recently commented on MDT shares. Jefferies Group LLC cut their price target on Medtronic PLC from $103.00 to $96.00 and set a “buy” rating on the stock in a report on Wednesday, August 23rd. Deutsche Bank AG set a $96.00 price target on Medtronic PLC and gave the company a “buy” rating in a report on Monday, July 31st. BidaskClub lowered Medtronic PLC from a “strong-buy” rating to a “buy” rating in a report on Monday, July 24th. Oppenheimer Holdings, Inc. restated a “buy” rating on shares of Medtronic PLC in a report on Tuesday, July 18th. Finally, Cowen and Company set a $95.00 price target on Medtronic PLC and gave the company a “buy” rating in a report on Tuesday, August 22nd. Three equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and thirteen have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $87.88.

In other news, CEO Omar Ishrak sold 140,407 shares of the company’s stock in a transaction that occurred on Friday, September 15th. The stock was sold at an average price of $81.63, for a total value of $11,461,423.41. Following the transaction, the chief executive officer now owns 668,503 shares of the company’s stock, valued at $54,569,899.89. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Bryan C. Hanson sold 16,000 shares of the company’s stock in a transaction that occurred on Monday, October 16th. The shares were sold at an average price of $78.03, for a total value of $1,248,480.00. The disclosure for this sale can be found here. 0.31% of the stock is currently owned by corporate insiders.

Medtronic PLC (NYSE MDT) opened at $79.33 on Monday. Medtronic PLC has a 12-month low of $69.35 and a 12-month high of $89.72. The company has a debt-to-equity ratio of 0.51, a current ratio of 1.64 and a quick ratio of 1.40. The company has a market capitalization of $107,459.70, a P/E ratio of 16.92, a PEG ratio of 2.19 and a beta of 1.00.

Medtronic PLC (NYSE:MDT) last posted its earnings results on Tuesday, August 22nd. The medical technology company reported $1.12 EPS for the quarter, beating the consensus estimate of $1.08 by $0.04. Medtronic PLC had a return on equity of 12.92% and a net margin of 13.75%. The company had revenue of $7.39 billion for the quarter, compared to the consensus estimate of $7.44 billion. During the same quarter in the prior year, the business earned $1.03 earnings per share. The firm’s revenue for the quarter was up 3.1% on a year-over-year basis. sell-side analysts expect that Medtronic PLC will post 4.66 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which was paid on Friday, October 20th. Stockholders of record on Friday, September 29th were given a $0.46 dividend. This represents a $1.84 annualized dividend and a dividend yield of 2.32%. The ex-dividend date was Thursday, September 28th. Medtronic PLC’s payout ratio is 61.95%.

Medtronic PLC Company Profile

Medtronic Public Limited Company (Medtronic) is a medical technology and services company. The Company develops, manufactures and markets its medical devices and technologies to hospitals, physicians, clinicians and patients in approximately 160 countries. The Company operates in four segments: Cardiac and Vascular Group, Minimally Invasive Technologies Group, Restorative Therapies Group and Diabetes Group.

Institutional Ownership by Quarter for Medtronic PLC (NYSE:MDT)

Receive News & Ratings for Medtronic PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Medtronic PLC and related companies with MarketBeat.com's FREE daily email newsletter.